New liver cancer treatment begins first human testing
NCT ID NCT07201064
Summary
This is a very early study to check if a new injection called SZ1003 is safe and tolerable for people with advanced liver cancer. It will involve 12 patients whose cancer has continued to grow after trying at least two other standard treatments. The main goal is to find a safe dose and watch for side effects over 24 weeks, while also looking for early signs that the treatment might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.